Home health providers are in for a rough session after Baird downgrades the entire sector to sell and slashes price targets. Noting the stocks have moved up in anticipation of the best outcome for the Medicare update, Baird says the actual result - including the rebase - couldn't have been worse. "Importantly, CMS's methodology ties its hands and leaves very little hope for a large reprieve in the final rule." AMED -12.8%, GTIV -11.7%, AFAM -9.5%, LHCG -5.9% premarket.
Home health providers are in for a rough session after Baird downgrades the entire sector to...
From other sites
Video at CNBC.com (Dec 8, 2015)
at CNBC.com (Aug 26, 2014)
at CNBC.com (Jun 27, 2014)
at CNBC.com (Oct 6, 2011)
at CNBC.com (Jul 7, 2011)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs